Literature DB >> 30759050

Predictors of substance use treatment initiation and engagement among adult and adolescent Medicaid recipients.

Bonnie K Lind1,2,3, Dennis McCarty3, Yifan Gu1, Robin Baker3, K John McConnell1,2.   

Abstract

Background: It is important to understand patterns and predictors of initiation and engagement in treatment for Medicaid-covered individuals with substance use disorders because Medicaid is a major source of payment for addiction treatment in the United States. Our analysis examined similarities and differences in predictors between adults and adolescents.
Methods: An analysis of Oregon Medicaid claims data for the time period January 2010 through June 2015 assessed rates of substance use and of treatment initiation and engagement using the Healthcare Effectiveness Data and Information Set (HEDIS) definitions. The analysis included individuals aged 13-64 with a new alcohol and other drug dependence diagnosis who met the HEDIS enrollment criteria and did not have cancer. We created 4 logistic regression models to assess treatment initiation and engagement, separately for adults (ages 18-64) and adolescents (ages 13-17). Independent predictors included age, gender, race, the interaction of gender and race, urban/rural residence, presence of any chronic disease, a psychiatric diagnosis, or a pain diagnosis.
Results: Among adults, odds of initiation were lower in white males than in nonwhite males, white females, and nonwhite females. Conversely, among adolescents, odds of initiation were higher in white males than in the other gender/race groups. Predictors of initiation also went in opposite directions for presence of a psychiatric diagnosis (negative in adults, positive in adolescents) and urban residence (positive in adults, negative in adolescents). We found similar patterns in models of engagement, although for engagement those with a psychiatric diagnosis had lower odds of engagement in both adults and adolescents. Conclusions: Predictors of treatment initiation and engagement for alcohol and drug use disorders differed between adults and adolescents on Medicaid. A better understanding of these differences will enable development of targeted treatment programs that are effective within age groups.

Entities:  

Keywords:  Medicaid; Substance use disorder; performance measures; substance use disorder treatment

Year:  2019        PMID: 30759050      PMCID: PMC6692250          DOI: 10.1080/08897077.2018.1550467

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  15 in total

1.  Results of a statewide survey of adolescent substance use screening rates and practices in primary care.

Authors:  Sion Kim Harris; Kathleen Herr-Zaya; Zohar Weinstein; Kathleen Whelton; Fernando Perfas; Carolyn Castro-Donlan; John Straus; Karen Schoneman; Michael Botticelli; Sharon Levy
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

Review 2.  Addressing substance misuse in adolescents: a review of the literature on the screening, brief intervention, and referral to treatment model.

Authors:  Aimee Beaton; Catherine D Shubkin; Steven Chapman
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

3.  Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.

Authors:  Scott E Hadland; J Frank Wharam; Mark A Schuster; Fang Zhang; Jeffrey H Samet; Marc R Larochelle
Journal:  JAMA Pediatr       Date:  2017-08-01       Impact factor: 16.193

4.  A novel approach to treating adolescents with opioid use disorder in pediatric primary care.

Authors:  Sharon Levy; Shannon Mountain-Ray; Jason Reynolds; Steven J Mendes; Jonas Bromberg
Journal:  Subst Abus       Date:  2018-04-26       Impact factor: 3.716

5.  Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform.

Authors:  Christina Andrews; Amanda Abraham; Colleen M Grogan; Harold A Pollack; Clifford Bersamira; Keith Humphreys; Peter Friedmann
Journal:  Health Aff (Millwood)       Date:  2015-05       Impact factor: 6.301

6.  Does Mandated Treatment Benefit Youth? A Prospective Investigation of Adolescent Justice System Involvement, Treatment Motivation, and Substance Use Outcomes.

Authors:  Julie D Yeterian; M Claire Greene; Brandon G Bergman; John F Kelly
Journal:  Alcohol Treat Q       Date:  2013-01-01

7.  Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement.

Authors:  Bobbi Jo H Yarborough; Felicia W Chi; Carla A Green; Agatha Hinman; Jennifer Mertens; Arne Beck; Michael Horberg; Constance Weisner; Cynthia I Campbell
Journal:  J Addict Med       Date:  2018 Jul/Aug       Impact factor: 3.702

8.  Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.

Authors:  Janet R Cummings; Hefei Wen; Michelle Ko; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2014-02       Impact factor: 21.596

9.  Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.

Authors:  Mark D Sullivan; Mark J Edlund; Ming-Yu Fan; Andrea DeVries; Jennifer Brennan Braden; Bradley C Martin
Journal:  Pain       Date:  2008-06-10       Impact factor: 6.961

10.  Adolescent Substance Abuse and Mental Health: Problem Co-Occurrence and Access to Services.

Authors:  Erin L Winstanley; Donald M Steinwachs; Maxine L Stitzer; Marc J Fishman
Journal:  J Child Adolesc Subst Abuse       Date:  2012-07-01
View more
  3 in total

1.  Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.

Authors:  Kelsey C Priest; Travis I Lovejoy; Honora Englander; Sarah Shull; Dennis McCarty
Journal:  J Gen Intern Med       Date:  2020-04-14       Impact factor: 5.128

2.  Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study.

Authors:  Alexandria Macmadu; Kimberly Paull; Rouba Youssef; Sivakumar Batthala; Kevin H Wilson; Elizabeth A Samuels; Jesse L Yedinak; Brandon D L Marshall
Journal:  Drug Alcohol Depend       Date:  2020-11-23       Impact factor: 4.492

3.  Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.

Authors:  Angela M Parcesepe; Kathryn Lancaster; E Jennifer Edelman; Raquel DeBoni; Jeremy Ross; Lukoye Atwoli; Mpho Tlali; Keri Althoff; Judicaël Tine; Stephany N Duda; C William Wester; Denis Nash
Journal:  PLoS One       Date:  2020-08-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.